HER2-specific autologous CAR VST
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2-specific autologous CAR VST, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]